Anatara's CEO, Steve Lydeamore will be presenting to investors at AusBiotech + Invest 2020 on 29th October 2020. Register to attend free for qualified investors.
Health & Pharm General
Anatara Lifesciences (ASX:ANR) is pleased to release to investors a copy of the presentation that Chief Executive Officer, Mr. Steven Lydeamore, will present today at the ASX Small and Mid-Cap Conference 2020, a virtual conference.
In this Open Briefing(R), Managing Director, Andrew McLellan discusses Bluechiip's (ASX:BCT) 2020 financial results, the Annual Report and the outlook for 2021.
Steven Lydeamore, Chief Executive Officer, Anatara Lifesciences (ASX:ANR) will be presenting at the ASX Small and Mid-Cap Conference 2020.
Ellis Martin Report: Science Editor Dr. Thomas Glenn and Zhittya Genesis Medicine's Dr. Jack Jacobs.
In this segment, Dr. Jacobs of Zhittya Genesis Medicine and Ellis Martin are joined by the Science Editor of the Ellis Martin Report, Dr. Thomas Glenn.
Regeneus Ltd (ASX:RGS), a clinical-stage regenerative medicine company, is pleased to announce that is has received a payment of 100M JPY (~A$1.3M) from Kyocera Corporation (Kyocera, TYO:6971)
The Group reported a consolidated loss after providing for income tax for the financial year ended 30 June 2020 of $4,501,085, compared to a consolidated loss of $3,257,996 for the financial year ended 30 June 2019.
Banking & Finance
- NSX Ltd (ASX:NSX) Trade Acceptance Service NSXA Go-Live Date 23 November
- NSX Ltd (ASX:NSX) Annual Report to Shareholders 2020
- Manningham Community Enterprises Limited (NSX:DCE) Annual Report 2020
Oil Gas & Energy
- Deep Yellow Limited (ASX:DYL) Corporate Update Presentation
- MEC Resources Limited (ASX:MMR) Announces Company Development and Board Changes
- Central Petroleum Limited (ASX:CTP) New Gas Sales Agreement and Finance Facility Extension